AARON NILES HOLLENBAUGH
Allopathic & Osteopathic Physicians|Internal Medicine LAS CRUCES, NM NPI 1073132148
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine NM Acerta Pharma LLC All categories
General Payments — all program years on this page
$245.16
- Category: General Payments
- Program years: PY2023–2024
- Record count: 10
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $200.44 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $200.44 | 8 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $80.22 | 3 |
| ABBVIE INC. | $74.12 | 3 |
| E.R. Squibb & Sons, L.L.C. | $27.61 | 1 |
| Janssen Pharmaceuticals, Inc | $18.49 | 1 |
By program year
Records — PY2024 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1078098816 | Janssen Pharmaceuticals, Inc | $18.49 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1101353704 | E.R. Squibb & Sons, L.L.C. | $27.61 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1103931286 | ABBVIE INC. | $30.11 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1103931288 | ABBVIE INC. | $25.69 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1103931290 | ABBVIE INC. | $18.32 | 08/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1104386919 | AstraZeneca Pharmaceuticals LP | $34.05 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1105487769 | AstraZeneca Pharmaceuticals LP | $20.59 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1105621357 | AstraZeneca Pharmaceuticals LP | $25.58 | 01/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.